Nayak Sanjay 4
4 · OCULAR THERAPEUTIX, INC · Filed Feb 25, 2026
Insider Transaction Report
Form 4
Nayak Sanjay
Chief Strategy Officer
Transactions
- Sale
Common Stock
[F1][F2]2026-02-23$8.28/sh−1,759$14,565→ 330,653 total
Footnotes (2)
- [F1]Represents shares of common stock of Ocular Therapeutix, Inc. (the "Corporation") sold, pursuant to a durable automatic sale instruction adopted by the reporting person on February 21, 2024, effecting the sell-to-cover election of the reporting person to satisfy tax withholding obligations in connection with the vesting of restricted stock units on February 22, 2026. The sales do not represent a discretionary trade by the reporting person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $8.2100 to $8.3300, inclusive. The reporting person undertakes to provide to the Corporation, any security holder of the Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (2) to this Form 4.
Signature
/s/ Todd Anderman, Attorney-in-Fact for Sanjay Nayak|2026-02-25